SCA
ALDR

Secor Capital Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Secor Capital Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,996
Closed -$143K – 642
2018
Q4 		$143K Buy
+13,996
New +$179K 0.02% 435
2018
Q2 		– Sell
-42,942
Closed -$545K – 694
2018
Q1 		$545K Sell
42,942
-122,942
-74% -$1.78M 0.04% 367
2017
Q4 		$1.9M Buy
165,884
+64,665
+64% +$722K 0.08% 208
2017
Q3 		$1.24M Buy
101,219
+8,459
+9% +$88.2K 0.12% 243
2017
Q2 		$1.06M Buy
+92,760
New +$1.71M 0.1% 270

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Secor Capital Advisors's ALDR Position: Q1 2019 in Review

Secor Capital Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 13,996 shares — an estimated $143K sold.

Secor Capital Advisors first reported a position in ALDR in Q2 2017 and held it in 5 quarters. The position peaked at $1.9M in Q4 2017. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Secor Capital Advisors reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Secor Capital Advisors sold 13,996 Alder Biopharmaceuticals shares in Q1 2019, an estimated $143K.
  • Secor Capital Advisors first reported a position in Alder Biopharmaceuticals in Q2 2017 and held it in 5 quarters.
  • Secor Capital Advisors's Alder Biopharmaceuticals position peaked at $1.9M in Q4 2017.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.